What is Vivex?
VIVEX is a pioneer in regenerative medicine, specializing in the development of naturally sourced treatment options and solutions that improve clinical, surgical, and therapeutic patient care through innovation. With tissue damage resulting from a variety of diseases, direct injury, and trauma, there is a significant need for advanced solutions. By leveraging the resources of the nation's oldest civilian tissue bank, VIVEX is channeling the body's inherent healing qualities to bring patients optimal care and to provide medical professionals and patients with innovative treatment options for a broad range of indications.
How much funding has Vivex raised?
Vivex has raised a total of $21.9M across 3 funding rounds:
Series A
$6.6M
Private Equity
$6.3M
Debt
$9M
Series A (2015): $6.6M, investors not publicly disclosed
Private Equity (2017): $6.3M, investors not publicly disclosed
Debt (2017): $9M supported by Heritage Bank of Commerce
Key Investors in Vivex
Heritage Bank of Commerce
Heritage Bank of Commerce, established in 1994, is a financial institution based in San Jose, California, with a focus on business banking and commercial lending.
What's next for Vivex?
The recent major strategic investment in Vivex signals a strong confidence from its backers in the company's trajectory within the regenerative medicine market. This capital infusion is expected to fuel further research and development, potentially expanding its innovative treatment options for a broad range of indications. The company's focus on leveraging inherent healing qualities positions it for significant advancements in patient care and therapeutic solutions.
See full Vivex company page
